C83.28 Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, lymph nodes of multiple sites

Name of the Condition

• Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, lymph nodes of multiple sites
• Also known as ICD-10 code C83.28

Summary

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of both small and large lymphoid cells in a diffuse pattern. It typically involves abnormal growth of B-cells or T-cells in lymph nodes of multiple sites, without forming follicular structures. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior depending on the specific cell composition and distribution.

Causes

The exact cause of mixed small and large cell (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in multiple areas.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or PET scans), and biopsy of affected lymph nodes. Pathologists analyze tissue samples to confirm the presence of mixed small and large cell morphology and rule out other lymphoma subtypes. Additional tests, such as flow cytometry or genetic studies, may be used to characterize the lymphoma cells and guide treatment decisions.

Treatment Options

Treatment depends on the stage, location, and patient factors. Common approaches include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. Clinical trials may be an option for some patients. Treatment plans are individualized based on the specific characteristics of the lymphoma and the patient's overall health.

Prognosis and Follow-Up

Prognosis varies based on factors like disease stage, cell type, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term surveillance helps manage potential late effects of therapy and detect complications early.

Complications

• Disease progression or transformation to a more aggressive subtype.
• Infections due to impaired immune function.
• Side effects from treatment, such as fatigue, nausea, or organ toxicity.
• Metastasis to other organs.

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support overall health.
• Avoid known carcinogens, such as tobacco or excessive alcohol.
• Practice good hygiene to reduce infection risk.
• Stay up-to-date with vaccinations, as recommended by a healthcare provider.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or night sweats. Early evaluation is important for timely diagnosis and treatment planning.

Tips for Medical Coders

When coding for C83.28, ensure documentation specifies "lymph nodes of multiple sites" to justify the code. Verify that the diagnosis aligns with the mixed small and large cell (diffuse) morphology and non-Hodgkin's lymphoma classification. Confirm no more specific site code applies before using this code.